Exponent Acquires Chanelle Pharma from Founder Michael H Burke

February 7, 2024

Exponent, a European private equity firm, has agreed to acquire Chanelle Pharma, Ireland’s largest indigenous manufacturer of generic human and veterinary pharmaceuticals, from founder Michael H Burke. The deal, terms undisclosed, positions Exponent to invest in Chanelle’s R&D, manufacturing capabilities and international growth across its presence in Ireland, the UK, Europe and Jordan.

Buyers
Exponent
Targets
Chanelle Pharma
Sellers
Michael H Burke
Industry
Pharmaceuticals
Location
Ireland
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.